ABOUT US

Curing mankind since 1976, Miln Laboratories (India) Private Limited is a

flourishing enterprise dedicated to delivering a product that can take care of
you and your loved ones. We are involved in manufacturing, developing and
exporting pharmaceuticals, which have been produced in strict cGMP
compliant facilities.
We have three dedicated plants, first for manufacture
of Penicillin formulations, second for non-Penicillin
formulations and third for liquid orals, creams and
ointments. While the range of penicillin dosage forms
includes tablets, dry syrups and capsules, the nonpenicillin range covers tablets, capsules, dry syrups,
liquid orals and creams and ointments.
We believe that our cGMP-imbued personnel are our
biggest assets as they perpetually upgrade their knowledge and apply the same
for producing & delivering quality products. Thus, the result of this a tude is a
pharmaceu cal product produced by professionals through a blend of scien c
acuity and pharmaceu cal art.
The fact that we are present in more than 43 countries with over 100 marke ng authoriza ons and the
several Quality Cer ca ons, awards and approvals that we have to our credit are the evidence of the same.
Con nual improvement is our policy as the company has been adap ng to current trends and requirements
while adding newer approvals and opening newer markets for business with each passing day.
The latest cGMP norms are a habit and Quality is our culture.
Upcoming Manufacturing Facility

We are presently expanding and building a new manufacturing facility to cater to the regulated
markets - USA and UK.
This fully integrated state-of-the-art manufacturing plant is situated at Dahej (Guajarat), in an area of
37664 Sq. Mt.
The facility will be dedicated for Oral solid dosage forms.

info.milanlabs.com

QUALITY PRODUCTS

Assurance of quality is provided by the quality systems adopted by Milan. The in-process controls, usage of
qualied machinery, validated manufacturing processes, validated cleaning procedures, strict environmental
monitoring and microbiological controls in all areas, are just a few of the many controls exercised by Milan to
ensure that Quality is built into the product. Furthermore, adequate training of personnel, maintaining
hygiene and cleanliness, proper recording and data handling compliment to our stringent quality policy.
The Quality Control sec on is well equipped with professionals opera ng Sophis cated instruments for
performing analysis of incoming materials, in process and nished products.
The plants are inspected by the Drug Regulatory Authori es of various countries and the constant eorts by
the Quality Opera ons cell has enabled us to have a very good success rate so far with registra ons in several
countries.

THERAPEUTIC SEGMENTS COVERED

Milan has made its own contribu on with a wide range of well-known products in various segments. Our wide
range of products encompasses an array of therapeu c segments.
The present product range of Milan is divided into its divisions focusing on various therapeu c segments.
v

An -bacterials

An -infec ves

An -allergics

Cardiovasculars

Anthelmen cs

An -malarials

An - diabe cs

An -inammatory, An -pyre cs, Analgesics

Dosage
Forms

www.milanlabs.com

APPROVALS WE HOLD
Our products are manufactured in facilities that have approvals from stringent regulatory authorities
like....
Botswana: Ministry of Health
Bhutan: Drug Regulatory Authority
Cte dIvorie : Ministry of Health
Democratic Republic of Congo: Ministry of Health
Ethiopia: Drug Administration and Control Authorithy
Ghana: Foods and Drugs Board
India: WHO cGMP Cer ed

Kenya: Pharmacy & Poisons Board

Malawi: Pharmacy, Medicines and Poison Board
Namibia: Namibia Medicines and Regulatory Council
Nigeria: National Agency for Food & Drug Administration & Control
Republic of Angola: Ministry of Health
Sierra Leone: Pharmacy Board
South Africa: Medicines Control Council (PIC Country)
Sudan: Ministry of Health
Tanzania: Tanzania Food and Drugs Authority
Uganda: National Drug Authority
United Kingdom: Medicines and Healthcare products Regulatory Agency
Ukraine: Ministry of Health
Zimbabwe: Medicines Control Authority Of Zimbabwe

info.milanlabs.com

MARKETS WE CATER
As on March, 2015, India Brand Equity Founda on quotes India as one of the fastest-growing pharmaceu cal
markets in the world and that India has established itself as a global manufacturing and research hub. A large raw
material base and the availability of a skilled workforce give the industry a denite compe ve advantage.
The Indian pharmaceu cal industry was es mated to be worth US$ 12 billion in 2013 and is expected to touch
US$ 100 billion by 2025
Globally, India ranks third in terms of volume of produc on and fourteenth largest by value and is also
expected to move up to eleventh place by 2017
Indian pharma sales stood at US$ 22.6 billion in 2012 and is expected to register US$ 27 billion by 2016 growing
at a rate of 14.4 percent
The pharmaceu cal exports market in India is growing at a very rapid rate.
India exports to more than 200 countries; its share of exports is expected to grow manifold
Pharmaceu cal exports from India grew at a rate of 1.2 per cent to reach US$ 14.84 billion in 2013-14
Looking at this the world is now considering India as the protable venue to manufacture its pharmaceu cal
products. Pharma export market in India is very poten al for the buyers for procuring their required
pharmaceu cal formula ons in all the available dosage forms.
Milan has achieved remarkable success in expor ng pharmaceu cal products to over 43 countries spread in all
the con nents of the world. We are looking forward to make such e-ups and nd new customers to whom we can
oer our spare capacity and export pharmaceu cal formula ons to the markets where we are s ll not present.

www.milanlabs.com

RESEARCH AND DEVELOPMENT

Pharmaceu cal Industry is a non-stagnant, forever evolving
industry, that demands new formula ons and improved
ecacy. To comply with these needs and to deliver maximum
pa ent compliance, a dedicated Research and Development
Facility is constantly engaged in developing dierent types of
generic/o-patent formula ons. Apart from working on new
products, the R&D also improvises on the exis ng formula ons
at Milan, thus ensuring not only the quality but also be er
products. The R&D is also engaged in analy cal method
development and valida on for the drug and drug formula ons
under development.
The Research and Development team comprises of highly
competent professionals including experts with more than 25 years of experience in pharmaceu cals who are
passionate about the cra of Formula ons and Development.

REGULATORY AFFAIRS
Milan also has an independent regulatory aairs team which is dedicated for dossier prepara on and
coordina on with drug authori es of dierent countries. This team comprises of qualied individuals who are,
constantly upda ng their knowledge and informa on bank to make dossier which is country specic, ecient in
query solving and comple ng registra on formali es within melines.
This team is procient in regulatory submissions like CTD
ACTD
NeeS
NeeS
eCTD
Any other country specic format

Other

eCTD
CTD

info.milanlabs.com

ACTD

YOUR TRUSTED PARTNER FOR ALL QUALITY PHARMACEUTICAL REQUIREMENTS

Marke ng Assistance

Research & Development

High Quality
Manufacturing

Regulatory Aairs

Complete Technical
Support

www.milanlabs.com

We manufacture only those quality products,

which we can safely give to our
Parents and Children.

303-304, Odyssey IT Park, Wagle Estate, Road No. 9, Thane (w) - 400604, Maharashtra, India.
Tel No.: +91-22-25877733/ 34, Fax No: +91-22-25877736
Email: info@milanlabs.com, Website: www.milanlabs.com